Updating results

701 results

Sort: Relevance | Date

Osteoarthritis

Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2019

Rheumatoid arthritis

Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart

NICE Pathway Published April 2013 Last updated August 2019

Trauma

Everything NICE has said on assessing and managing trauma in an interactive flowchart

NICE Pathway Published February 2016 Last updated August 2019

Health of people in the criminal justice system

Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system

NICE Pathway Published November 2016 Last updated August 2019

Community pharmacies: promoting health and wellbeing

Everything NICE has said on how community pharmacies can promote health and wellbeing in an interactive flowchart

NICE Pathway Published August 2018 Last updated August 2019

Hypertension

Everything NICE has said on managing hypertension in adults in an interactive flowchart

NICE Pathway Published August 2011 Last updated August 2019

Type 2 diabetes in adults

Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Chest pain

Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart

NICE Pathway Published November 2016 Last updated June 2019

Physical activity

Everything NICE has said on interventions, programmes and strategies to encourage people of all ages to be physically active in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Stroke

Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

NICE Pathway Published May 2011 Last updated May 2019

Type 1 diabetes in adults

Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Ovarian cancer

Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

NICE Pathway Published February 2012 Last updated August 2019

Learning disability: care and support of people growing older (QS187)

This quality standard covers identifying, assessing and regularly reviewing the care and support needs of people with a learning disability as they grow older. People with a learning disability have many of the same age-related health and social care needs as other people, but this quality standard focuses on the specific challenges associated with their learning disability. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2019

Twin and triplet pregnancy

Everything NICE has said on managing twin and triplet pregnancies in the antenatal and intrapartum period in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Prostatitis – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for acute prostatitis in an interactive flowchart.

NICE Pathway Published October 2018 Last updated September 2019

Tuberculosis

Everything NICE has said on preventing, diagnosing and managing latent and active tuberculosis in an interactive flowchart

NICE Pathway Published January 2012 Last updated September 2019

Chronic obstructive pulmonary disease

Everything NICE has said on diagnosing and managing chronic obstructive pulmonary disease in people aged 16 and over in an interactive flowchart

NICE Pathway Published May 2011 Last updated September 2019

Bronchiectasis (non-cystic fibrosis) – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for managing and preventing an acute exacerbation of bronchiectasis (non-cystic fibrosis) in an interactive flowchart

NICE Pathway Published December 2018 Last updated September 2019

Urinary tract infections

Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

NICE Pathway Published August 2012 Last updated September 2019

Suicide prevention (QS189)

This quality standard covers ways to reduce suicide and help people bereaved or affected by suicide. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2019

Multiple pregnancy: twin and triplet pregnancies (QS46)

This quality standard covers the additional antenatal care for women who are pregnant with twins or triplets that is offered alongside routine antenatal care. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2013 Last updated September 2019

Service user experience in adult mental health services

Everything NICE has said on improving the experience of care for people using adult NHS mental health services in an interactive flowchart

NICE Pathway Published March 2012 Last updated September 2019

Self-harm

Everything NICE has said on assessing and managing self-harm in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Endocrine cancers

Everything NICE has said on endocrine cancers in an interactive flowchart

NICE Pathway Published March 2018 Last updated September 2019

Suicide prevention

Everything NICE has said on preventing suicide in community and residential custodial and detention settings in an interactive flowchart

NICE Pathway Published September 2018 Last updated September 2019

Ear, nose and throat conditions

Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

NICE Pathway Published November 2013 Last updated September 2019

Safe midwifery staffing for maternity settings

Everything NICE has said on safe midwifery staffing requirements for maternity settings in an interactive flowchart

NICE Pathway Published February 2015 Last updated September 2019

Lung cancer in adults (QS17)

This quality standard covers diagnosing and managing lung cancer in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

Quality standard Published March 2012 Last updated September 2019

Head injury

Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart

NICE Pathway Published January 2014 Last updated September 2019

Attention deficit hyperactivity disorder

Everything NICE has said on diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults in an interactive flowchart

NICE Pathway Published July 2013 Last updated September 2019

Lung cancer

Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

NICE Pathway Published March 2012 Last updated September 2019

Cabozantinib for previously treated advanced hepatocellular carcinoma (terminated appraisal) (TA582)

NICE is unable to make a recommendation about the use in the NHS of cabozantinib (Cometriq) for previously treated advanced hepatocellular carcinoma in adults

Technology appraisal guidance Published May 2019

Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) (TA576)

NICE is unable to make a recommendation about the use in the NHS of bosutinib for untreated chronic myeloid leukaemia because no evidence submission was

Technology appraisal guidance Published April 2019

Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) (TA570)

NICE is unable to make a recommendation about the use in the NHS of pembrolizumab (Keytruda) for treating recurrent or metastatic squamous cell carcinoma of the

Technology appraisal guidance Published March 2019

Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality (TA322)

Evidence-based recommendations on lenalidomide (Revlimid) for myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

Technology appraisal guidance Published September 2014 Last updated June 2019

Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies (TA171)

Evidence-based recommendations on lenalidomide (Revlimid) for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance Published June 2009 Last updated June 2019

Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) (TA594)

NICE is unable to make a recommendation about the use in the NHS of brentuximab vedotin (Adcetris) for untreated advanced Hodgkin lymphoma in adults

Technology appraisal guidance Published August 2019

Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA595)

Evidence-based recommendations on dacomitinib (Vizimpro) for locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (NSCLC) in adults

Technology appraisal guidance Published August 2019

Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (TA593)

Evidence-based recommendations on ribociclib (Kisqali) for hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer in adults

Technology appraisal guidance Published August 2019

Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma (TA592)

Evidence-based recommendations on cemiplimab (Libtayo) for treating locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC) in adults

Technology appraisal guidance Published August 2019

Risankizumab for treating moderate to severe plaque psoriasis (TA596)

Evidence-based recommendations on risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults

Technology appraisal guidance Published August 2019

Bisphosphonates for treating osteoporosis (TA464)

Evidence-based recommendations on bisphosphonates (alendronic acid; ibandronic acid; risedronate sodium; zoledronic acid) for treating osteoporosis in adults

Technology appraisal guidance Published August 2017 Last updated July 2019

Enzalutamide for hormone-relapsed non-metastatic prostate cancer (TA580)

Evidence-based recommendations on enzalutamide (Xtandi) for treating high-risk hormone-relapsed non-metastatic prostate cancer in adults

Technology appraisal guidance Published May 2019

Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy (TA579)

Evidence-based recommendations on abemaciclib (Verzenios) for treating hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer

Technology appraisal guidance Published May 2019

Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer (TA584)

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin), carboplatin and paclitaxel for metastatic non-squamous NSCLC

Technology appraisal guidance Published June 2019

Nivolumab with ipilimumab for untreated advanced renal cell carcinoma (TA581)

Evidence-based recommendations on nivolumab (Opdivo) with ipilimumab (Yervoy) for untreated advanced renal cell carcinoma in adults

Technology appraisal guidance Published May 2019

Ocrelizumab for treating primary progressive multiple sclerosis (TA585)

Evidence-based recommendations on ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (MS) in adults

Technology appraisal guidance Published June 2019

Dapagliflozin with insulin for treating type 1 diabetes (TA597)

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for type 1 diabetes not controlled by insulin therapy alone in adults with a BMI of at

Technology appraisal guidance Published August 2019

Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma (TA577)

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive cutaneous T-cell lymphoma in adults

Technology appraisal guidance Published April 2019

Durvalumab for treating locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation (TA578)

Evidence-based recommendations on durvalumab (Imfinzi) for treating locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation

Technology appraisal guidance Published May 2019